These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 24661651)

  • 81. Long-term outcomes of breast-conserving therapy for women with ductal carcinoma in situ.
    Warren LEG; Chen YH; Halasz LM; Brock JE; Capuco A; Punglia RS; Wong JS; Golshan M; Bellon JR
    Breast Cancer Res Treat; 2019 Dec; 178(3):607-615. PubMed ID: 31493031
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Impact of margin status on local recurrence after mastectomy for ductal carcinoma in situ.
    Childs SK; Chen YH; Duggan MM; Golshan M; Pochebit S; Punglia RS; Wong JS; Bellon JR
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(4):948-52. PubMed ID: 22975615
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Changes in temporal patterns of local failure after breast-conserving therapy and their prognostic implications.
    Krauss DJ; Kestin LL; Mitchell C; Martinez AA; Vicini FA
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):731-40. PubMed ID: 15465189
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Assessing the benefit of radiation therapy after breast-conserving surgery for ductal carcinoma-in-situ.
    Hayman JA; Kabeto MU; Schipper MJ; Bennett JE; Vicini FA; Pierce LJ
    J Clin Oncol; 2005 Aug; 23(22):5171-7. PubMed ID: 16051959
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Rationalization and regionalization of treatment for ductal carcinoma in situ of the breast.
    Smith GL; Smith BD; Haffty BG
    Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1397-403. PubMed ID: 16750316
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Long-term Survival Comparison of Repeated Breast-conserving Surgery Versus Mastectomy for Patients with DCIS with Ipsilateral Breast Tumor Recurrence: A Real-world Longitudinal Study.
    Li Q; Wang K; Yang L; Wu Q; Zhu W; Li Z; Shi Y; Zhang X; Li H
    Clin Breast Cancer; 2021 Aug; 21(4):360-372. PubMed ID: 33846099
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Outcomes after breast conservation treatment with radiation in women with ductal carcinoma in situ and prior nonbreast malignancy.
    Shah DN; Vapiwala N; Solin LJ
    Breast J; 2009; 15(6):649-52. PubMed ID: 19995380
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Outcomes in patients treated with mastectomy for ductal carcinoma in situ.
    Owen D; Tyldesley S; Alexander C; Speers C; Truong P; Nichol A; Wai ES
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):e129-34. PubMed ID: 23195778
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Radiotherapy after mastectomy for screen-detected ductal carcinoma in situ.
    Clements K; Dodwell D; Lawrence G; Ball G; Francis A; Pinder S; Sawyer E; Wallis M; Thompson AM;
    Eur J Surg Oncol; 2015 Oct; 41(10):1406-10. PubMed ID: 26314790
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Significance of boost radiotherapy in early invasive ductal breast cancer with ductal carcinoma in situ component under negative surgical margins.
    Shimizu N; Myojin M; Tamura M; Nishiyama N; Yamashiro K; Yuyama Y; Okazaki Y; Suzuki Y; Takahashi M
    J Radiat Res; 2022 Jan; 63(1):80-87. PubMed ID: 34718690
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Breast conserving treatment for ductal carcinoma in situ in the elderly: can radiation therapy be avoided? Our experience.
    Falco G; Rocco N; Procaccini E; Sommella MG; Bordoni D; Cenini E; Castagnetti F; Sabatino V; Compagna R; Della Corte GA; Accurso A; Amato B; Ferrari G
    Int J Surg; 2014; 12 Suppl 2():S47-S49. PubMed ID: 25167849
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Multigene Expression Assay and Benefit of Radiotherapy After Breast Conservation in Ductal Carcinoma in Situ.
    Rakovitch E; Nofech-Mozes S; Hanna W; Sutradhar R; Baehner FL; Miller DP; Fong C; Gu S; Tuck A; Sengupta S; Elavathil L; Jani PA; Bonin M; Chang MC; Slodkowska E; Anderson JM; Cherbavaz DB; Shak S; Paszat L
    J Natl Cancer Inst; 2017 Apr; 109(4):. PubMed ID: 30053207
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853. EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group.
    Julien JP; Bijker N; Fentiman IS; Peterse JL; Delledonne V; Rouanet P; Avril A; Sylvester R; Mignolet F; Bartelink H; Van Dongen JA
    Lancet; 2000 Feb; 355(9203):528-33. PubMed ID: 10683002
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Radiotherapy versus low-dose tamoxifen following breast-conserving surgery for low-risk and estrogen receptor-positive breast ductal carcinoma in situ: an international open-label randomized non-inferiority trial (TBCC-ARO DCIS Trial).
    Kuo SH; Tseng LM; Chen ST; Sagara Y; Chang YC; Yeh HT; Kuo YL; Hung CC; Lu TP; Lee YH; Toi M; Huang CS
    BMC Cancer; 2023 Sep; 23(1):865. PubMed ID: 37710198
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Age at diagnosis and outcome for women with ductal carcinoma-in-situ of the breast: a critical review of the literature.
    Vicini FA; Recht A
    J Clin Oncol; 2002 Jun; 20(11):2736-44. PubMed ID: 12039936
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Ten-year results of applying an original scoring system for addressing adjuvant therapy use after breast-conserving surgery for ductal carcinoma in situ of the breast.
    Gennaro M; De Santis MC; Mariani L; Lo Vullo S; Cappelletti V; Agresti R; Cortinovis U; Paolini B; Di Cosimo S; Carcangiu ML; Daidone MG; Lozza L
    Breast; 2017 Oct; 35():63-68. PubMed ID: 28651115
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Final results from a multicenter prospective study ( JROSG 05-5) on postoperative radiotherapy for patients with ductal carcinoma in situ with an involved surgical margin or close margin widths of 1 mm or less.
    Shikama N; Sekiguchi K; Nakamura N; Sekine H; Nakayama Y; Imanaka K; Akiba T; Aoki M; Hatayama Y; Ogo E; Kagami Y; Kawashima M; Karasawa K
    J Radiat Res; 2015 Sep; 56(5):830-4. PubMed ID: 26093369
    [TBL] [Abstract][Full Text] [Related]  

  • 98. The impact of genomic testing on the recommendation for radiation therapy in patients with ductal carcinoma in situ: A prospective clinical utility assessment of the 12-gene DCIS score™ result.
    Alvarado M; Carter DL; Guenther JM; Hagans J; Lei RY; Leonard CE; Manders J; Sing AP; Broder MS; Cherepanov D; Chang E; Eagan M; Hsiao W; Schultz MJ
    J Surg Oncol; 2015 Jun; 111(8):935-40. PubMed ID: 26031501
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Aggressive local treatment for screen-detected DCIS results in very low rates of recurrence.
    Jha MK; Avlonitis VS; Griffith CD; Lennard TW; Wilson RG; McLean LM; Dawes PD; Shrimankar J
    Eur J Surg Oncol; 2001 Aug; 27(5):454-8. PubMed ID: 11504515
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Ductal carcinoma in situ (DCIS) treated by mastectomy, or local excision with or without radiotherapy: A monocentric, retrospective study of 608 women.
    Frank S; Dupont A; Teixeira L; Porcher R; De Roquancourt A; Giacchetti S; Espié M; Cuvier C
    Breast; 2016 Feb; 25():51-6. PubMed ID: 26573444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.